Nutritional High International Inc. Ordinary Shares C.NHL

RE:RE:Nutritional High

[Greede]

Superbly stated.

LiquidOctopus wrote:

You need to move on from what this company was in 2017.  They've clearly reoriented their focus to the Western US and have enjoyed success there, on par with any other player you can mention.  It was clearly a little jarring for investors to have this company switch gears but things have moved rapidly since they've developed the "new core vision".  And just rebuffing this by saying Calyx was great when they bought it (which it was) isn't sufficient.  Calyx was doing, according to Adam, $200,000/mo when they bought it.  Now it's doing $1.3-1.5 (as of the last quarter).  You already know this. 

You're so knowledgeable on the current events but you've made it clear you don't trust Posner.  Stock performance alone can't tell you if the management is good.  You think they're not good managers but they were smart enough to smell money in California, and now they distribute for many strong production companies, including Plus Products.  As for their own production, it's pretty small scale in California.  We'll see how that ramps up this year.  The review I found online for the chocolate bar was very positive.  So there is nothing from that perspective that should hold them back.  Basically, the managment isn't dumb.  Adam is smart.  Tom is smart.  Jim looks like a corpse when he's interviewed, likely because he works 90 hours a week.   If they were total boobs, I don't think we'd be by the Docklight hanging with the Privateers or on the 420 list of top earners.  

Imagine your worst case scenario where NH starts to falter under debt and puts itself up for sale (this in not the scenario I consider likely btw).  Assuming Continuum and Calyx are both roughly the same size, what do you think a distribution platform like that is worth in California?  It's actually worth lots.  Cresco Labs could have an interest in being the first in line to buy Nutritional High.  They would then have very dominant position in California distribution and avoid another big player with surplus cash just swooping in and assuming the role of chief rival for California distribution (Aurora, for example).  They've built value Geod, it just hasn't translated to your portfolio yet. 

A buyout is still in the cards.  That's something we agree on.  

And lastly, I believe (having never been to Nevada) that Tsunami does drinks.  Such a product, as you so desire should be in the corporate family.  

geodcan wrote: has a lot of ambition but have met with the reality of inevitable delay by law and policy makers.  I'm having doubts that our team is structured to deliver on multiple objectives and have complicated things by trying to be everything, everywhere without really showing the success that is going to be needed to go forth and multiply.  I can't even keep my head wrapped around all of the deals that have been announced as though they are fact that have only turned out to be fleeting visions.  Investors tire of that quickly and move on and there are a lot to move on to.  I've been tracking some US companies that segwayed into the pharma end of the marijuana biz in their respective States and are making great headway and most recenly have been applying for and getting Canadian stock listings to raise capital to expand their pharma businesses beyond and into the rec market.  Most recently Canopy Growth, who are leading the pack of future mega companies moved on the legislation that straightened out CBD regulations (farm bill) and felt righteous enough to make big investments on US soil, heavily anticipating that rec weed legalization will soon follow and can convert over to rec from pharma in the time it takes to grow a crop, when they won't run afoul of the law.  Canada's innovation has led the way and politicians are watching closely for when their time comes.  Of course it is law and politics that drag everything to what we as investors feel is a snail's pace, but things are happening and the will of the people will prevail.  Lots of plusses for marijuana over alcohol and opiodes as well as anxiety psychoactive anti-depressants that kill a lot of joy seekers and patients alike and EAT's original idea of edibles still has merit over smokable ingestion like vapes and such.  Fact is a lot of people have lung problems and can't inhale without detriment, so edibles is a niche.  I do feel very strongly that beverages will dominate and I know that EAT has mentioned several efforts at providing those and Big Alcohol knows that "funtime" beverages will displace a lot of marketshare which is why Canopy Growth and Constellation were the first to synergise each other with potential and the cash to do it.  Canopy Growth has earned first place in the marijuana business and continues to garner respect for their execution to be a world player and leader, by picking up strategic pieces for their puzzle that is the future of marijuana and hemp.  There success comes from being pro-active and futuristic thinkers rather than re-active to events around them and they are willing to buy the IP and bricks and mortar to make that happen, but what they do makes sense to me, unlike some of the coatailing that EAT has done.  I really want to see EAT succeed on its own but now I would like to see other eyes on our puzzle pieces as an acquisition.  glta and dyodd